Cargando…
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients
BACKGROUND: We previously showed that metabolomics predicts relapse in early breast cancer (eBC) patients, unselected by age. This study aims to identify a “metabolic signature” that differentiates eBC from advanced breast cancer (aBC) patients, and to investigate its potential prognostic role in an...
Autores principales: | Risi, Emanuela, Lisanti, Camilla, Vignoli, Alessia, Biagioni, Chiara, Paderi, Agnese, Cappadona, Silvia, Monte, Francesca Del, Moretti, Erica, Sanna, Giuseppina, Livraghi, Luca, Malorni, Luca, Benelli, Matteo, Puglisi, Fabio, Luchinat, Claudio, Tenori, Leonardo, Biganzoli, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676351/ https://www.ncbi.nlm.nih.gov/pubmed/36403505 http://dx.doi.org/10.1016/j.tranon.2022.101585 |
Ejemplares similares
-
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer
por: Vignoli, Alessia, et al.
Publicado: (2021) -
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
por: McCartney, Amelia, et al.
Publicado: (2019) -
The role of abemaciclib in treatment of advanced breast cancer
por: McCartney, Amelia, et al.
Publicado: (2018) -
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer
por: Migliaccio, Ilenia, et al.
Publicado: (2022) -
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting
por: Di Donato, Samantha, et al.
Publicado: (2021)